20959 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
Nanopatterned medical device with enhanced cellular interaction
#602PANCREATIC STELLATE CELL SPECIFIC PROMOTER AND USES THEREOF
#603Solvent/polymer solutions as suspension vehicles
#604CONJUGATES FOR THE TREATMENT OF MESOTHELIOMA
#605TREATMENT OF PROLIFERATIVE DISORDERS WITH A DEATH RECEPTOR AGONIST
#606METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#607Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
#608Cell capable of expressing exogenous GITR ligand
#609Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer
#610Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy
#611Orally administrable immunostimulant product for aquaculture
#612Dimeric Smac mimetics
#613ACTIVE VARIANTS OF THE IL-18 BINDING PROTEIN AND MEDICAL USES THEREOF
#614Antibody therapy
#615USE OF TLR AGONISTS AND/OR TYPE 1 INTERFERONS TO ALLEVIATE TOXICITY OF TNF-R AGONIST THERAPEUTIC REGIMENS
#616Inducer of chondrocyte proliferation and differentiation
#617COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha
#618Antiviral nucleosides
#619TRAIL VARIANTS FOR TREATING CANCER
#620LIGHT inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment
#621Methods and compositions for liquidation of tumors
#622COMPOSITION FOR TREATING ARTICULAR CARTILAGE DEFECT, AND METHOD OF MANUFACTURE THEREOF
#623METHOD AND SYSTEM TO REMOVE SOLUBLE TNFR1, TNFR2, AND IL2 IN PATIENTS
#624Methods and compositions for modulating adipocyte function
#625IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#626Cyclic, cystein-free protein
#627Metabolically activated recombinant viral vectors and methods for their preparation and use
#628Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
#629USE OF THE COMBINATION COMPRISING TEMOZOLOMIDE AND TNF-ALPHA FOR TREATING GLIOBLASTOMA
#630Restoration of hearing loss
#631Defined culture conditions of human embryonic stem cells
#632IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#633LIPOPOLYSACCHARIDE ISOLATED FROM PYRULARIA TISSUE AND/OR PYRULARIA-ASSOCIATED BACTERIA AND USES THEREOF
#634HUMAN BONE-FORMING CELLS IN THE TREATMENT OF CONDITIONS AND BONE DISEASES ASSOCIATED WITH IMMUNODEFICIENCY OR IMMUNOSUPPRESSION
#635METHOD TO ENHANCE HEMATOPOIESIS
#636Pharmaceutical composition comprising a cytokine
#637TAJ in Neuronal Function
#638STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY
#639Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof
#640Method and compositions for prevention and treatment of diabetic and aged skin
#641Methods of suppressing microglial activation
#642Antibody-light fusion products for cancer therapeutics
#643Antiviral nucleosides
#644Nanotherapeutic colloidal metal compositions and methods
#645Q3 SPARC DELETION MUTANT AND USES THEREOF
#646MODULATORS OF PARAPTOSIS AND RELATED METHODS
#647Novel Peptides and Their Use for the Treatment of Edema
#648Method of treating rheumatoid arthritis with an IL-6R antibody
#649Compositions and methods for treatment of angiogenesis in pathological lesions
#650Immunoconjugates for the treatment of tumours
#651VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#652THERAPEUTIC REGIMEN FOR TREATING CANCER
#653COMPOSITION FOR ENHANCING BONE FORMATION
#654Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#655DELIVERY OF BINDING MOLECULES TO INDUCE IMMUNOMODULATION
#656TREATMENT AND/OR PREVENTION OF CANCER AND/OR ARTHRITIS
#657Methods and compositions for oral administration of protein and peptide therapeutic agents
#658SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#659ENHANCEMENT OF ANTIBODY-CYTOKINE FUSION PROTEIN MEDIATED IMMUNE RESPONSES BY COMBINED TREATMENT WITH IMMUNOCYTOKINE UPTAKE ENHANCING AGENTS
#660METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF INSULIN
#661Modulation of Gamma-Delta T Cells to Regulate Airway Hyperresponsiveness
#662Compositions and methods for promoting bone formation
#663Targeted vectors for cancer immunotherapy
#664Suppression of immune response to factor VIII in hemophilia A patients
#665Pharmaceutical Compositions for the Treatment of TNF-Alpha Related Disorders
#666Tumor necrosis factor-alpha mutants
#667Antibody therapy
#668Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells
#669Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells in a matrix
#670Enhanced medical implant comprising disrupted tooth pulp and tooth particles
#671COMPOUNDS THAT INHIBIT OESTRONE SULPHATASE; COMPOSITIONS THEREOF; AND METHODS EMPLOYING THE SAME
#672MODIFIED CYTOKINES FOR USE IN CANCER THERAPY
#673Ligands of HVEM for treating hematologic malignancies
#674Sequential administration of a replication defective adenovirus vector in vaccination protocols
#675Synergism Between Activated Immune Cells and Conventional Cancer Therapies
#676Enhanced medical implant comprising disrupted tooth pulp and tooth particles
#677Method of treating cancer by combination therapy using TNF and alpha-galactosylceramide
#678Methods and compositions for treating autoimmune diseases
#679Viral vectors
#680Colloidal metal compositions and methods
#681Trimeric OX40-immunoglobulin fusion protein and methods of use
#682Antiviral nucleosides
#683P2Xinhibition of epithelial cancers and papillomas
#684Methods for Treatment of HIV and Other Infections Using A T Cell or Viral Activator and Anti-Retroviral Combination Therapy
#685Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN
#686Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein
#687Liposome and method for producing the same
#688Sensitizing Cells for Apoptosis by Selectively Blocking Cytokines
#689CHEMOKINES AS ADJUVANTS OF IMMUNE RESPONSE
#690Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies
#691METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#692Methods of organ regeneration using Hox11-expressing pluripotent cells
#693COMBINATION WITH BIS (THIOHYDRAZIDE AMIDES) FOR TREATING CANCER
#694Vaccine immunotherapy
#695METHOD FOR THE ADMINISTRATION OF LIGANDS, AGONISTS OF LIGANDS OF THE TNF FAMILY WITH REDUCED TOXICITY
#696Methods and compositions for treatment of retinoid-responsive conditions
#697Repair of the Bone Marrow Vasculature
#698Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
#699METHODS FOR THE TREATMENT OF PSORIASIS OR PSORIATIC ARTHRITIS USING CYCLOPROPYL-N-CARBOXAMIDE
#700MOLECULES AND CHIMERIC MOLECULES THEREOF
#701Methods for using GEP, a chondrogenic growth factor and target in cartilage disorders
#702Immunodynamic complexes and methods for using and preparing such complexes
#703METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL
#704VEGF-activated ligands
#705Methods of Alleviating Disorders and Their Associated Pain
#706METHOD OF TREATING CANCER
#707N-terminal modified PEG-TRAIL
#708Kit containing stem cells and cytokines for use in attenuating immune responses
#709Compositions and methods for treatment of microbial disorders
#710Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
#711Pancreatic Islet Cell Preparation and Transplantation
#712Methods of suppressing microglial activation and systemic inflammatory responses
#713USE OF A COMBINATION OF OLOPATADINE AND CILOMILAST TO TREAT NON-INFECTIOUS RHINITIS AND ALLERGIC CONJUNCTIVITIS
#714METHODS OF TREATING ALZHEIMER'S DISEASE
#715ADMINISTRATION OF THERAPEUTIC VIRUSES
#716VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#717METHODS OF SUPPRESSING MICROGLIAL ACTIVATION AND SYSTEMIC INFLAMMATORY RESPONSES
#718Use of a Compound with RANKL Activity
#719Preparation and application of biodegradable-material-made microsphere vascular embolus containing liposome-encapsulated cytokines
#720Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-R
#721LIGHT Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment
#722Bivalent SMAC mimetics and the uses thereof
#723ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS
#724INHIBITORS OF SERINE PROTEASE ACTIVITY AND THEIR USE IN METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL
#725COMBINATION THERAPY FOR TREATING CANCER
#726Antibody therapy
#727REVERSAL OF VIRAL-INDUCED SYSTEMIC SHOCK AND RESPIRATORY DISTRESS BY BLOCKADE OF THE LYMPHOTOXIN BETA PATHWAY
#728Infection and treatment of neoplasms with vesicular stomatitis virus
#729Immunostimulatory Combinations for Vaccine Adjuvants
#730Bioactive molecular matrix and methods of use in the treatment of disease
#731Dendritic cell stimulatory factor
#732HUMAN THERAPIES USING CHIMERIC AGONISTIC ANTI-HUMAN CD40 ANTIBODY
#733Therapy for primary and metastatic cancers
#734KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF A CALRETICULIN PROTEIN TO A CELLULAR MEMBRANE
#735CONDITIONED BLOOD COMPOSITION AND METHOD FOR ITS PRODUCTION
#736MODULATORS OF PARAPTOSIS AND RELATED METHODS
#737TREATMENT AND/OR PREVENTION OF CANCER AND/OR ARTHRITIS
#738COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alpha
#739NOD1 as an Anti-Tumor Agent
#740PHARMACEUTICAL COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT OR ERP57 TRANSLOCATION
#741SERVICE FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT TRANSLOCATION
#742METHOD FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING ERP57 TRANSLOCATION
#743SERVICE FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING ERP57 TRANSLOCATION
#744Porous objects having immobilized encapsulated biomolecules
#745Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
#746Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
#747Treatment of Autoimmune Diseases and Allograft Rejection with IL-21
#748Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease
#749METHOD TO ENHANCE HEMATOPOIESIS
#750Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof
#751Use of Baff to Treat Th2-Mediated Conditions
#752Use of an Inhibitor of TNFa Plus an Antihistamine to Treat Allergic Rhinitis and Allergic Conjunctivitis
#753PHARMACEUTICAL COMPOSITION COMPRISING A CYTOKINE
#754Method of treating immune pathologies with low dose estrogen
#755METHOD FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT TRANSLOCATION
#756Method of treating immune pathologies with low dose estrogen
#757Use of cyclosporin A to sensitize resistant cancer cells to death receptor ligands
#758Metabolically activated recombinant viral vectors and methods for their preparation and use
#759METHOD OF CANCER SCREENING; METHOD OF CANCER TREATMENT; AND METHOD OF AUTO-IMMUNE DISEASE TREATMENT
#760Pharmaceutical compositions for the treatment of TNF-α related disorders
#761Q3 SPARC DELETION MUTANT AND USES THEREOF
#762Methods for identifying modulators of tumor necrosis factor receptors
#763Compositions and methods for soft tissue repair
#764Antiviral nucleosides
#765Methods of suppressing microglial activation
#766METHOD AND SYSTEM TO REMOVE SOLUBLE TNFR1, TNFR2, AND IL2 IN PATIENTS
#767Composition and Methods For Inhibiting Cell Survival
#768Method for altering the CD4/CD8 ratio and the mononuclear cellular infiltrate into a tumor
#769TREATMENT OF RHEUMATOID ARTHRITIS WITH SOLUBLE FAS-LIGAND CROSS-LINKERS
#770Compositions Containing Agm Cells And Methods Of Use Thereof
#771Bivalent Smac mimetics and the uses thereof
#772Active Variants of the Il-18 Binding Protein and Medical Uses Thereof
#773Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine
#774Method for Managing Cholesterol with a Serum-Free and Mitogen-Free Cytokine Mixture
#775Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity
#776Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
#777METHOD FOR USING CALCIUM-SENSITIVE POTASSIUM CHANNEL AGONIST FOR DELIVERING A MEDICANT TO AN ABNORMAL BRAIN REGION AND/OR A MALIGNANT TUMOR
#778Targeted gene delivery for dendritic cell vaccination
#779Compositions and Methods for Treating Hypertension and Inflammation
#780Methods and Compositions for Viral Enhancement of Cell Killing
#781Composition comprising a pulmonary surfactant and a TNF-derived peptide
#782Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules
#783Compositions and methods for promoting myocardial and peripheral angiogenesis
#784Combination of a Histone Deacetylase Inhibitor with a Death Receptor Ligand
#785Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
#786Treating Skin Cancer
#787Colloidal metal compositions and methods
#788Chemoprevention of endometrial cancer
#789USE OF THE COMBINATION COMPRISING TEMOZOLOMIDE AND TNF-ALPHA FOR TREATING GLIOBLASTOMA
#790TNF-alpha VARIANTS PROTEINS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS
#791Immunomodulating compositions and uses therefor
#792ANTIBODY THERAPY
#793Methods for inhibiting osteoclast differentiation, formation, or function and for increasing bone mass
#794METHOD TO ENHANCE HEMATOPOIESIS
#795METHOD OF CANCER SCREENING; METHOD OF CANCER TREATMENT; AND METHOD OF DIABETES TREATMENT
#796TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS
#797THERAPEUTIC REGIMEN FOR TREATING CANCER
#798CHEMOKINES AS ADJUVANTS OF IMMUNE RESPONSE
#799METHOD FOR MODULATING HLA CLASS II TUMOR CELL SURFACE EXPRESSION WITH A CYTOKINE MIXTURE
#800PSMA antibody-drug conjugates
#801Colloidal metal compositions and methods
#802Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions
#803METHOD OF CANCER SCREENING; METHOD OF CANCER TREATMENT; AND METHOD OF DIABETES TREATMENT
#804METHOD OF CANCER SCREENING; METHOD OF CANCER TREATMENT; AND METHOD OF DIABETES TREATMENT
#805Method for selective expression of therapeutic genes by hyperthermia
#806Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
#807CHEMOKINES AS ADJUVANTS OF IMMUNE RESPONSE
#808Hox11+, CD45− cells and methods of organ regeneration using the same
#809Use of NF-B inhibition in combination therapy for cancer
#810Medicinal composition for treatment of chronic hepatitis c
#811Use of NF-κB inhibition in combination therapy for cancer
#812Metabolically activated recombinant viral vectors and methods for their preparation and use
#813Novel delivery of immune response modifiers for removal of chronic tattoos
#814Treatment for heart disease
#815Multiribbon nanocellulose as a matrix for wound healing
#816Vaccine immunotherapy for immune suppressed patients
#817Modified cytokines for use in cancer therapy
#818Activation of Egr-1 promoter by DNA damaging chemotherapeutics
#819Vaccine immunotherapy for immune suppressed patients
#820Vaccine immunotherapy
#821Method of cancer screening; method of cancer treatment; and method of diabetes treatment
#822Compositions and methods involving MDA-7 for the treatment of cancer
#823Medicament and use thereof for tumor therapy
#824Adenoviral vectors for treating diseases
#825Trimeric OX40-immunoglobulin fusion protein and methods of use
#826Therapeutic use of tumor necrosis factor-alpha mutein
#827Sensitizing cells for apoptosis by selectively blocking cytokines
#828Adenoviral vectors for treating diseases
#829Adenoviral vectors for treating diseases
#830Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders
#831Method for modulating HLA class II tumor cell surface expression with a cytokine mixture
#832Targeted vectors for cancer immunotherapy
#833Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-R
#834Q3 SPARC deletion mutant and uses thereof
#835NOD1 as an anti-tumor agent
#836Immunotherapy for immune suppressed patients
#837Solvent/polymer solutions as suspension vehicles
#838Methods for the treatment of infectious and inflammatory airway diseases
#839Viral vectors
#840Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor
#841Genetically modified tumor cells as cancer vaccines
#842Ubiquitinated TNF receptor2 and its uses
#843Vaccine immunotherapy for immune suppressed patients
#844Modified cytokines for use in cancer therapy
#845Method of cancer screening; method of cancer treatment; method of diabetes treatment; method of multiple sclerosis treatment; method of prophylaxis and treatment of avian influenza
#846Oxaliplatin anti-resistance agent
#847Means and methods for the modulation of arteriogenesis
#848Method of cancer screening; method of cancer treatment; and method of diabetes treatment
#849Method of cancer screening; method of cancer treatment; and method of diabetes treatment
#850Method of cancer treatment; method of diabetes treatment; method of multiple sclerosis treatment; method of interstitial cystitis treatment; method of acquired immune deficiency syndrome treatment; and method of herpes treatment
#851Method of cancer screening; method of cancer treatment; and method of diabetes treatment
#852Method of cancer screening; method of cancer treatment; and method of diabetes treatment
#853Method of cancer screening; method of cancer treatment; method of diabetes treatment; method of multiple sclerosis treatment; method of interstitial cystitis treatment; method of acquired immune deficiency syndrome treatment; and method of herpes treatment
#854Method of cancer screening; method of cancer treatment; and method of diabetes treatment
#855Methods of promoting neurite outgrowth with soluble TAJ polypeptides
#856Methods and compositions for delivery of an enhanced response to antigenic substrates
#857Methods of suppressing microglial activation
#858Compositions and methods to modulate an immune response to an immunogenic therapeutic agent
#859Anti-lymphotoxin-β receptor antibodies as anti-tumor agents
#860Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients
#861Modified cytokines for use in cancer therapy
#862Immunodynamic complexes and methods for using and preparing such complexes
#863Protein based TNF-α variants for the treatment of TNF-α related disorders
#864Methods and compositions for treatment of neurological disorder
#865Immunodynamic complexes and methods for using and preparing such complexes
#866Modulators of paraptosis and related methods
#867Methods for treating cancer using vascular endothelial cell growth inhibitor VEGI-192A
#868Combination therapy comprising a Cox-2 inhibitor and an antineoplastic agent
#869Administration of therapeutic viruses
#870Combined therapeutical treatment of hyperproliferative diseases
#871Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy
#872Combination therapies with L-FMAU for the treatment of hepatitis B virus infection
#873Methods and compositions for modulating adipocyte function
#874Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins
#875Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
#876Treatment of TNF-α related disorders with TNF-α variant proteins
#877Novel application of vaccination against TNF-alpha
#878Functionalized colloidal metal compositions and methods
#879Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
#880Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture
#881Treatment of rheumatoid arthritis with soluble Fas-ligand cross-linkers
#882Methods of organ regeneration using -expressing pluripotent cells
#883Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture
#884Vaccine immunotherapy for immune suppressed patients
#885Methods and compositions for viral enhancement of cell killing
#886Compositions and methods for promoting myocardial and peripheral angiogenesis
#887Method for the administration of ligands, agonists of ligands of the TNF family with reduced toxicity
#888Tumor necrosis factor combined with interferon in demyelinating diseases
#889Cellular vaccines and immunotherapeutics and methods for their preparation
#890Use NF-B inhibition in combination therapy for cancer
#891Method to enhance hematopoiesis
#892Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
#893Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
#894Novel complementing receptor-ligand pairs and adoptive immunotherapy using the same
#895Immunoconjugates for the treatment of tumours
#896Modulation of gamma delta T cells to regulate airway hyperresponsiveness
#897Method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture
#898Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture